Qvents

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Qvents Qvents
  • Home 
    • About Us 
    • Contact Us 
    • Expert Panel 
    • Tags 
  • Qvents 
    • Warning Letters 
    • 483s 
    • Recalls 
    • Import Alerts 
    • Quality Insights 
    • Tags 
  • Forum 
  • Learning Resources 
    • Upcoming Trainings 
    • Training Archives 
  • Guidelines 
  • Pharma Jobs 
    • Job Openings 
    • Post Job
      • Jobs posted by me 
  • Users & Profiles 
  • News 
  • Login/Register
    • Individual
    • Company
Qvents Qvents
Qvents
  • Home 
    • About Us 
    • Contact Us 
    • Expert Panel 
    • Tags 
  • Qvents 
    • Warning Letters 
    • 483s 
    • Recalls 
    • Import Alerts 
    • Quality Insights 
    • Tags 
  • Forum 
  • Learning Resources 
    • Upcoming Trainings 
    • Training Archives 
  • Guidelines 
  • Pharma Jobs 
    • Job Openings 
    • Post Job
      • Jobs posted by me 
  • Users & Profiles 
  • News 
  • Login/Register
shape
shape
shape
shape

483s

USFDA 483 to Laurus: Lapses in cleaning,

Laurus, Visakh was issued USFDA 483 with five (5) observations following USFDA inspection by investigators

Venksin
June 16, 2025

USFDA 483 to Laurus: Lapses in investiga

Laurus, Visakh was issued USFDA 483 with five (5) observations following USFDA inspection by investigators

Venksin
March 27, 2025

Feb 27 test

testing

Qvents
February 27, 2025

Test 26 feb 123456

asdd test 123

Author Test
February 26, 2025

USFDA 483 / UCB Farchim SA/ June 2023 /

USFDA Inspected UCB Farchim site at Bulle, Switzerland (FEI 3005023799) in June / July 2023.

Qvents
October 30, 2023

USFDA 483 / UCB Farchim SA/ June 2023 /

USFDA 483 / UCB Farchim SA/ June 2023 / Gaps in Data Integrity program, lack

Qvents
October 30, 2023

USFDA 483 / IPCA / June 2023 /Inadequate

IPCA unit at Dhar, Madhya Pradesh, India USFDA 483 cites Invalidation of OOS with inconclusive

Qvents
August 2, 2023

USFDA 483 / Intas / May 2023 /Failure to

USFDA 483 to Intas cites lapses in investigation and review of failures and discrepancies in

Qvents
July 24, 2023

USFDA 483 / Intas / May 2023 /Manipulati

USFDA483 to Intas cites manipulated visual inspection reports; failure to characterise particles observed in injection

Qvents
July 24, 2023

USFDA 483 / IPCA / June 2023 /Failure of

USFDA Inspected IPCA (Ratlam, India) site in June 2023, Inspectors – Rajiv R Srivastava, Salim

Qvents
July 7, 2023

1 2 … 4
  • Facebook
  • LinkedIn
  • Twitter

Search Posts

Latest Posts

healthy lifestyle
June 19, 2025
USFDA 483 to Laurus: Lapses in cleaning, documentation.
June 16, 2025
Aarti Drugs USFDA 483 Flags Unique Challenges of Generic Pharma Companies
June 16, 2025
Yiling Pharma Warning Letter: Equipment Duct Cleaning & Cross-Contamination Issues Flagged
June 14, 2025
Trial
June 13, 2025
footer shape 1
footer shape 2
Quick Links 
  • Warning Letters
  • 483s
  • Recalls
  • Import Alerts
  • Quality Insights
 
  • News
  • Guidelines
  • Pharma Jobs
  • Job Openings
  • Post a Job
 
  • Users & Profiles
  • Trainings and Webinar
  • About Us
  • Contact Us
  • Facebook
  • LinkedIn
  • Twitter

© 2024 All Rights Reserved by Qvents

  • Terms and Conditions
  • Privacy Policy